Hypertensive Disease Samples

Central BioHub offers Hypertensive Disease Samples which include the diseases Essential (primary) hypertension and Hypertensive heart disease. Use our filter functions to perform complex searches according to matrices, disease in clear name or ICD-10 code, laboratory parameters, medication and patient annotation like age, gender, BMI and ethnicity. For normal control groups please switch to the category Healthy Donors. If you do not find the samples you are looking for, please contact us.

Available filters
Donor Age
-
Donor BMI
-
72 Products

Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Female Age: 53 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine free (fT4) Triiodothyronine free (fT3)
Open
Donor:
Gender:
Female
Age:
53 Years
Ethnic group:
European/Caucasian
BMI:
43 kg/m²
Weight:
125 kg
Height:
171 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • E10.90
  • Mixed hyperlipidaemia [E78.2]
  • I10.90
Medication:
  • L-thyroxine (Dosages: 150not specified)
  • Ramipril (Dosages: 10mg)
  • Sormodren (Dosages: 4mg)
  • Toujeo
  • amlodipine (Dosages: 5mg)
  • atorvastatin (Dosages: 20mg)
  • fenofibrate (Dosages: 250not specified)
  • hydrochlorothiazide (HCT) (Dosages: 25mg)
  • insulin (insulin Fiasp)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: positive
Quant: 115.30 kIU/L
Source: previous donation
< 34.00 kIU/L
Method: not specified
System: Cobas Modular Roche
TSH Receptor Antibodies (TRAb)
Qual: negative
Quant: 0.46 IU/L
Source: previous donation
< 1.22 IU/L
Remarks: borderline: 1,22 - 1,75
Method: not specified
System: Cobas Modular Roche
Thyrotropin (TSH)
Qual: positive
Quant: 4.600 mU/L
Source: this donation
Remarks: sensitive
0.270 - 4.200 mU/L
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 e-Module Roche
Thyrotropin (TSH)
Qual: positive
Quant: 5.95 mIU/L
Source: previous donation
0.27 - 4.20 mIU/L
Method: not specified
System: not specified Roche
Thyroxine free (fT4)
Qual: negative
Quant: 14.10 pg/mL
Source: previous donation
9.30 - 17.00 pg/mL
Method: not specified
System: not specified Roche
Triiodothyronine free (fT3)
Qual: negative
Quant: 2.90 pg/mL
Source: previous donation
2.00 - 4.40 pg/mL
Method: not specified
System: not specified Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH273993
1 mL ($43.13)
Available ($225.00)

Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Female Age: 47 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Bisoprolol
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine free (fT4) Triiodothyronine free (fT3)
Open
Donor:
Gender:
Female
Age:
47 Years
Ethnic group:
European/Caucasian
BMI:
53 kg/m²
Weight:
152.4 kg
Height:
169 cm
Sample:
Matrix:
Serum
Condition:
slightly hemolytic
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • E11.90
  • I10.90
Medication:
  • Bisoprolol (Dosages: 2.5mg)
  • Desofemono
  • L-thyroxine
  • Valsartan
Therapy:
  • thyroid surgery
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 10.00 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual: negative
Quant: < 0.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 5.81 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine free (fT4)
Qual:
Quant: 18.80 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine free (fT3)
Qual:
Quant: 3.80 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH170874
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Capsule-reactive protein (CRP), Capsu... - I10.90

Donor:
Gender: Female Age: 73 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Brimica
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Open
Donor:
Gender:
Female
Age:
73 Years
Ethnic group:
European/Caucasian
BMI:
28 kg/m²
Weight:
65.3 kg
Height:
154 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Brimica
  • Ibuflam (Dosages: 800mg/day, active agent: ibuprofen)
  • Quensyl (active agent: hydroxychloroquine)
  • Tevanate (Dosages: 70mg/week)
  • Vigantoletten (Dosages: 1000IU/day)
  • leflunomide (Dosages: 10mg/day)
  • pantoprazole (Dosages: 20mg/day)
  • salbutamol (as needed)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 6.86 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 7.10 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 38.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: 11.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295903
1 mL ($43.13)
Available ($225.00)

Human Serum - Anti-Neutrophil Cytoplasmic Antibodie... - I10.9-

Donor:
Gender: Female Age: 56
Diagnosed disease:
I10.9-
Parameter:
25-Hydroxy-Vitamin D3 (Calcidiol) Anti-Jo-1 (a-histidyl-tRNA synthetase) Anti-Ku Anti-Mi-2 Anti-Mutated citrullinated Vimentin (MCV) Anti-Myeloperoxidase (MPO) Anti-Neutrophil Cytoplasmic Antibodies (ANCA) Anti-OJ Protein Anti-PL-12 Anti-PL-7 ...
Open
Donor:
Gender:
Female
Age:
56 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • I10.9-
Parameter Result Ref. / Cut-Off Measuring Information
25-Hydroxy-Vitamin D3 (Calcidiol)
Qual: negative
Quant: 42.30 ng/mL
Source: this donation
30.00 - 100 ng/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Anti-Jo-1 (a-histidyl-tRNA synthetase)
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Ku
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Mi-2
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Mutated citrullinated Vimentin (MCV)
Qual: negative
Quant: 1.40 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-Myeloperoxidase (MPO)
Qual: negative
Quant: 1.50 U/mL
Source: this donation
< 5.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-Neutrophil Cytoplasmic Antibodies (ANCA)
Qual:
Quant: not specified Titer
Source: this donation
Remarks: subsequent claim possible
negative Titer
Method: IIFT (Indirect Immunfluorescence Test)
System: iPro EUROIMMUN AG
Anti-OJ Protein
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-PL-12
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-PL-7
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-PM-Scl-100
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-PM-Scl-75
Qual:
Quant: low positive
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Proteinase 3 (PR3)
Qual: negative
Quant: 0.80 U/mL
Source: this donation
< 10.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-SS-A 52 kDa (Ro 52)
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Signal recognition particle (SRP)
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: 20.00 IU/mL
Source: this donation
< 100 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: Analyzer1 EUROIMMUN AG
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: negative
Quant: 10.00 IU/mL
Source: this donation
< 50.00 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: Analyzer1 EUROIMMUN AG
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: negative
Quant: 4.08 RU/mL
Source: this donation
< 5.00 RU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: Analyzer1 EUROIMMUN AG
Antinuclear Antibodies (ANA)
Qual: negative
Quant: Titer
Source: this donation
Remarks: VD AMA
negative Titer
Method: IIFT (Indirect Immunfluorescence Test)
System: IFSprinter EUROIMMUN AG
Bone alkaline phosphatase (BAP)
Qual: positive
Quant: 31.90 µg/L
Source: this donation
5.50 - 27.10 µg/L
Remarks: sex and age dependent
Method: EIA (Enzyme Immuno Assay)
System: ISYS IDS
Capsule-reactive protein (CRP)
Qual: negative
Quant: 2.94 mg/L
Source: this donation
0.00 - 3.00 mg/L
Method: Nephelometry
System: BN ProSpec Siemens
Complement C3
Qual: negative
Quant: 1.47 g/L
Source: this donation
0.90 - 1.80 g/L
Method: Nephelometry
System: BN ProSpec Siemens
Complement C4
Qual: negative
Quant: 0.32 g/L
Source: this donation
0.10 - 0.40 g/L
Method: Nephelometry
System: BN ProSpec Siemens
EJ-Protein
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Osteocalcin
Qual: positive
Quant: 10.20 ng/mL
Source: this donation
10.40 - 45.60 ng/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Parathyroid hormone (PTH)
Qual: negative
Quant: 38.70 pg/mL
Source: this donation
11.50 - 78.40 pg/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Rheumatoid Factor (RF) IgA
Qual: negative
Quant: 4.6 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Rheumatoid Factor (RF) IgG
Qual: negative
Quant: 2 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 1.00 IU/mL
Source: this donation
< 20.00 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Serum Crosslaps
Qual: negative
Quant: 0.19 ng/mL
Source: this donation
0.14 - 1.35 ng/mL
Remarks: sex and age dependent
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
TSH Receptor Antibodies (TRAb)
Qual: negative
Quant: 1.10 IU/L
Source: this donation
< 1.80 IU/L
Remarks: 1,80 - 2,00 borderline
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: Analyzer1 EUROIMMUN AG
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH193479
1.1 mL ($142.31)
Available ($225.00)

Human K3EDTA plasma - Glycosylated hemoglobin (HbA1, HbA1c) - E11.40

Donor:
Gender: Male Age: 55 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Aldactone
Parameter:
Glycosylated hemoglobin (HbA1, HbA1c)
Open
Donor:
Gender:
Male
Age:
55 Years
Ethnic group:
European/Caucasian
BMI:
33 kg/m²
Blood type:
Not specified
Rhesus factor:
not specified
Weight:
125 kg
Height:
196 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • E11.40
  • Postprocedural hypothyroidism [E89.0]
  • I10.90
Medication:
  • Aldactone (Dosages: 25not specified, active agent: spironolactone)
  • Atozet
  • Hygroton (Dosages: 25not specified, active agent: chlorthalidone)
  • Jardiance (Dosages: 10mg)
  • L-Thyrox (Dosages: 150not specified)
  • allopurinol (Dosages: 100not specified)
  • amlodipine (Dosages: 5mg)
  • insulin
  • metformin
  • no incretin mimetics
  • valsartan (Dosages: 80mg)
Parameter Result Ref. / Cut-Off Measuring Information
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: positive
Quant: 10.10 %
Source: this donation
4.00 - 6.00 %
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344377
1 mL ($43.13)
Available ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.40

Donor:
Gender: Male Age: 55 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Aldactone
Parameter:
Glycosylated hemoglobin (HbA1, HbA1c)
Open
Donor:
Gender:
Male
Age:
55 Years
Ethnic group:
European/Caucasian
BMI:
33 kg/m²
Blood type:
Not specified
Rhesus factor:
not specified
Weight:
125 kg
Height:
196 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • E11.40
  • Postprocedural hypothyroidism [E89.0]
  • I10.90
Medication:
  • Aldactone (Dosages: 25not specified, active agent: spironolactone)
  • Atozet
  • Hygroton (Dosages: 25not specified, active agent: chlorthalidone)
  • Jardiance (Dosages: 10mg)
  • L-Thyrox (Dosages: 150not specified)
  • allopurinol (Dosages: 100not specified)
  • amlodipine (Dosages: 5mg)
  • insulin
  • metformin
  • no incretin mimetics
  • valsartan (Dosages: 80mg)
Parameter Result Ref. / Cut-Off Measuring Information
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: positive
Quant: 10.10 %
Source: this donation
4.00 - 6.00 %
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344376
1 mL ($43.13)
Available ($225.00)

Human Li-heparin plasma - Glycosylated hemoglobin (HbA1, HbA1c) - E11.40

Donor:
Gender: Male Age: 55 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Aldactone
Parameter:
Glycosylated hemoglobin (HbA1, HbA1c)
Open
Donor:
Gender:
Male
Age:
55 Years
Ethnic group:
European/Caucasian
BMI:
33 kg/m²
Blood type:
Not specified
Rhesus factor:
not specified
Weight:
125 kg
Height:
196 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • E11.40
  • Postprocedural hypothyroidism [E89.0]
  • I10.90
Medication:
  • Aldactone (Dosages: 25not specified, active agent: spironolactone)
  • Atozet
  • Hygroton (Dosages: 25not specified, active agent: chlorthalidone)
  • Jardiance (Dosages: 10mg)
  • L-Thyrox (Dosages: 150not specified)
  • allopurinol (Dosages: 100not specified)
  • amlodipine (Dosages: 5mg)
  • insulin
  • metformin
  • no incretin mimetics
  • valsartan (Dosages: 80mg)
Parameter Result Ref. / Cut-Off Measuring Information
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: positive
Quant: 10.10 %
Source: this donation
4.00 - 6.00 %
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344378
1 mL ($43.13)
Available ($225.00)

Human Li-heparin plasma - C73

Donor:
Gender: Male Age: 59 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroglobulin (aTg / TAK)
Open
Donor:
Gender:
Male
Age:
59 Years
Ethnic group:
European/Caucasian
BMI:
35 kg/m²
Blood type:
Not specified
Rhesus factor:
not specified
Weight:
115 kg
Height:
182 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • C73
  • Postprocedural hypothyroidism [E89.0]
  • I10.90
Medication:
  • L-thyroxine (Dosages: 150not specified)
  • Ramipril (Dosages: 10mg)
  • amlodipine (Dosages: 5mg)
  • atorvastatin (Dosages: 20mg)
  • pramipexole (Dosages: 0.7mg)
Therapy:
  • thyroid surgery
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: < 0.09 kIU/L
Source: previous donation
< 115.00 kIU/L
Method: not specified
System: Cobas Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344251
1 mL ($43.13)
Available ($225.00)

Human K2EDTA plasma - C73

Donor:
Gender: Male Age: 59 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroglobulin (aTg / TAK)
Open
Donor:
Gender:
Male
Age:
59 Years
Ethnic group:
European/Caucasian
BMI:
35 kg/m²
Blood type:
Not specified
Rhesus factor:
not specified
Weight:
115 kg
Height:
182 cm
Sample:
Matrix:
K2EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • C73
  • Postprocedural hypothyroidism [E89.0]
  • I10.90
Medication:
  • L-thyroxine (Dosages: 150not specified)
  • Ramipril (Dosages: 10mg)
  • amlodipine (Dosages: 5mg)
  • atorvastatin (Dosages: 20mg)
  • pramipexole (Dosages: 0.7mg)
Therapy:
  • thyroid surgery
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: < 0.09 kIU/L
Source: previous donation
< 115.00 kIU/L
Method: not specified
System: Cobas Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344250
1 mL ($43.13)
Available ($225.00)

Human Serum - C73

Donor:
Gender: Male Age: 59 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroglobulin (aTg / TAK)
Open
Donor:
Gender:
Male
Age:
59 Years
Ethnic group:
European/Caucasian
BMI:
35 kg/m²
Blood type:
Not specified
Rhesus factor:
not specified
Weight:
115 kg
Height:
182 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • C73
  • Postprocedural hypothyroidism [E89.0]
  • I10.90
Medication:
  • L-thyroxine (Dosages: 150not specified)
  • Ramipril (Dosages: 10mg)
  • amlodipine (Dosages: 5mg)
  • atorvastatin (Dosages: 20mg)
  • pramipexole (Dosages: 0.7mg)
Therapy:
  • thyroid surgery
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: < 0.09 kIU/L
Source: previous donation
< 115.00 kIU/L
Method: not specified
System: Cobas Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344248
3.6 mL ($155.25)
Available ($225.00)

Human Serum - Thyrotropin (TSH) - E03.09

Donor:
Gender: Female Age: 29 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Duphaston
Parameter:
Thyrotropin (TSH) Thyroxine free (fT4) Triiodothyronine free (fT3)
Open
Donor:
Gender:
Female
Age:
29 Years
Ethnic group:
European/Caucasian
BMI:
52 kg/m²
Weight:
165 kg
Height:
178 cm
Sample:
Matrix:
Serum
Condition:
slightly lipemic
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.09]
  • E11.90
  • Other adrenocortical overactivity [E27.0]
  • I10.90
Medication:
  • Duphaston (Dosages: 10mg, active agent: dydrogesterone)
  • Eferox (Dosages: 125not specified)
  • Zanipress
  • loratadine
  • metformin (Dosages: 2000mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Thyrotropin (TSH)
Qual: negative
Quant: 2.770 mU/L
Source: this donation
Remarks: sensitive
0.270 - 4.200 mU/L
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 e-Module Roche
Thyrotropin (TSH)
Qual: positive
Quant: 5.07 mIU/L
Source: previous donation
0.27 - 4.20 mIU/L
Method: not specified
System: not specified Roche
Thyroxine free (fT4)
Qual: negative
Quant: 14.40 pg/mL
Source: previous donation
9.30 - 17.00 pg/mL
Method: not specified
System: not specified Roche
Triiodothyronine free (fT3)
Qual: negative
Quant: 3.70 pg/mL
Source: previous donation
2.00 - 4.40 pg/mL
Method: not specified
System: not specified Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH280003
1 mL ($43.13)
Available ($225.00)

Human Serum - Capsule-reactive protein (CRP), Capsu... - I10.90

Donor:
Gender: Male Age: 69 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Metex
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Open
Donor:
Gender:
Male
Age:
69 Years
Ethnic group:
European/Caucasian
BMI:
21 kg/m²
Weight:
62 kg
Height:
170 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Anamneses:
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 0 (information given at the time of donation) (negative RF and ACPA)
  • total points (ACR/EULAR criteria) 5 (information given at the time of donation)
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 0 (information given at the time of donation) (negative RF and ACPA)
  • total points (ACR/EULAR criteria) 5 (information given at the time of donation)
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 0 (information given at the time of donation) (negative RF and ACPA)
  • total points (ACR/EULAR criteria) 5 (information given at the time of donation)
Diseases:
  • I10.90
Medication:
  • Metex (Dosages: 7.5mg/week)
  • Prednisolon (Dosages: 2.5mg/day)
  • folic acid (Dosages: 5mg/week)
  • leflunomide (Dosages: 15mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 8.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 8.1 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 8.67 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 17.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH303753
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - I10.90

Donor:
Gender: Male Age: 57 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Metex
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Open
Donor:
Gender:
Male
Age:
57 Years
Ethnic group:
European/Caucasian
BMI:
29 kg/m²
Weight:
96 kg
Height:
181 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Anamneses:
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 5 (More than 10 joints, at least one small joint) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
  • total points (ACR/EULAR criteria) 10 (information given at the time of donation)
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 5 (More than 10 joints, at least one small joint) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
  • total points (ACR/EULAR criteria) 10 (information given at the time of donation)
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 5 (More than 10 joints, at least one small joint) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
  • total points (ACR/EULAR criteria) 10 (information given at the time of donation)
Diseases:
  • I10.90
Medication:
  • Metex (Dosages: 15mg/week)
  • Olumiant (Dosages: 4mg/day, active agent: baricitinib)
  • Ramipril (Dosages: 10mg/day)
  • alendronic acid (Dosages: 70mg/week)
  • amlodipine (Dosages: 10mg/day)
  • folic acid (Dosages: 5mg/week)
  • simvastatine (Dosages: 40mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: positive
Quant: > 500.00 IU/mL
Source: previous donation
< 17.00 IU/mL
Method: not specified
System: Cobas Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 3.93 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 25.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: positive
Quant: 99.00 IU/mL
Source: previous donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH303760
1 mL ($43.13)
Available ($225.00)

Human Serum - Capsule-reactive protein (CRP), Capsu... - I10.90

Donor:
Gender: Male Age: 78 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Lodotra
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Open
Donor:
Gender:
Male
Age:
78 Years
Ethnic group:
European/Caucasian
BMI:
29 kg/m²
Weight:
90 kg
Height:
176 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Anamneses:
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 0 (information given at the time of donation) (negative RF and ACPA)
  • total points (ACR/EULAR criteria) 5 (information given at the time of donation)
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 0 (information given at the time of donation) (negative RF and ACPA)
  • total points (ACR/EULAR criteria) 5 (information given at the time of donation)
Diseases:
  • I10.90
Medication:
  • Lodotra (Dosages: 50mg/day)
  • Metex (Dosages: 10mg/week)
  • Quensyl (active agent: hydroxychloroquine)
  • folic acid (Dosages: 5mg/week)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 8.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 37.09 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 37.2 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 61.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: 12 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH303749
1 mL ($43.13)
Available ($225.00)

Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Male Age: 38 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Metoprolol
Parameter:
Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine free (fT4) Triiodothyronine free (fT3)
Open
Donor:
Gender:
Male
Age:
38 Years
Ethnic group:
European/Caucasian
BMI:
31 kg/m²
Weight:
95.6 kg
Height:
176 cm
Sample:
Matrix:
Serum
Condition:
slightly hemolytic
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • E11.90
  • I10.90
Medication:
  • Metoprolol (Dosages: 95mg)
  • Ramipril
  • amlodipine
  • hydrochlorothiazide (HCT) (Dosages: 12.5mg)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: < 20.00 kU/L
Source: this donation
< 40.00 kU/L
Method: CLIA (Chemiluminescence Immuno Assay)
System: Immulite Siemens
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 16.90 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual:
Quant: 0.54 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual: negative
Quant: 1.30 mU/L
Source: this donation
Remarks: basal
0.35 - 4.94 mU/L
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Thyrotropin (TSH)
Qual:
Quant: 5.61 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine free (fT4)
Qual:
Quant: 10.80 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine free (fT3)
Qual:
Quant: 4.20 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH166796
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - I10.90

Donor:
Gender: Male Age: 79 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Metex
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Open
Donor:
Gender:
Male
Age:
79 Years
Ethnic group:
European/Caucasian
BMI:
30 kg/m²
Weight:
82 kg
Height:
165 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Metex (Dosages: 7.5mg/week)
  • folic acid (Dosages: 5mg/week)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: positive
Quant: 323.00 IU/mL
Source: previous donation
< 17.00 IU/mL
Method: not specified
System: Cobas Roche
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: positive
Quant: > 500.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 0.99 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 1.10 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 11.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: positive
Quant: 84.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: positive
Quant: 72.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292273
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - I10.90

Donor:
Gender: Female Age: 64 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Metex
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Open
Donor:
Gender:
Female
Age:
64 Years
Ethnic group:
European/Caucasian
BMI:
32 kg/m²
Weight:
107 kg
Height:
183 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Metex (Dosages: 10mg/week)
  • amlodipine (Dosages: 2.5mg/day)
  • folic acid (Dosages: 5mg/week)
  • valsartan
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: positive
Quant: 499.00 IU/mL
Source: previous donation
< 17.00 IU/mL
Method: not specified
System: Cobas Roche
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: positive
Quant: > 500.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 1.70 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 1.77 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 38.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: positive
Quant: 245.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: positive
Quant: 267.00 IU/mL
Source: previous donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292287
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Capsule-reactive protein (CRP), Capsu... - I10.90

Donor:
Gender: Female Age: 54 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Prednisolon
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Open
Donor:
Gender:
Female
Age:
54 Years
Ethnic group:
European/Caucasian
BMI:
22 kg/m²
Weight:
63 kg
Height:
169 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Prednisolon (Dosages: 5mg/day)
  • leflunomide (Dosages: 20mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 6.10 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 6.31 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 18.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: 11.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295904
1 mL ($43.13)
Available ($225.00)

Human Li-heparin plasma - Capsule-reactive protein (CRP), Capsu... - I10.90

Donor:
Gender: Female Age: 54 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Prednisolon
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Open
Donor:
Gender:
Female
Age:
54 Years
Ethnic group:
European/Caucasian
BMI:
22 kg/m²
Weight:
63 kg
Height:
169 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Prednisolon (Dosages: 5mg/day)
  • leflunomide (Dosages: 20mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 6.10 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 6.31 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 18.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: 11.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295905
1 mL ($43.13)
Available ($225.00)

Human Li-heparin plasma - Erythrocyte sedimentation rate (ESR) ... - I10.90

Donor:
Gender: Female Age: 69 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Olumiant
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total IgM Total Rheumatoid Factor (tRF)
Open
Donor:
Gender:
Female
Age:
69 Years
Ethnic group:
European/Caucasian
BMI:
38 kg/m²
Weight:
100 kg
Height:
162 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Olumiant (Dosages: 4mg/day, active agent: baricitinib)
  • folic acid (Dosages: 5mg/week)
  • methotrexate (Dosages: 7.5mg/week)
  • pantoprazole (Dosages: 20mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 3.40 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 3.57 mg/L
Source: previous donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 13.00 mm/1h
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total IgM
Qual: positive
Quant: 26.00 mg/dl
Source: this donation
40.00 - 230.00 mg/dl
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: previous donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295204
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - I10.90

Donor:
Gender: Female Age: 69 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Olumiant
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total IgM Total Rheumatoid Factor (tRF)
Open
Donor:
Gender:
Female
Age:
69 Years
Ethnic group:
European/Caucasian
BMI:
38 kg/m²
Weight:
100 kg
Height:
162 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Olumiant (Dosages: 4mg/day, active agent: baricitinib)
  • folic acid (Dosages: 5mg/week)
  • methotrexate (Dosages: 7.5mg/week)
  • pantoprazole (Dosages: 20mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 3.40 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 3.57 mg/L
Source: previous donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 13.00 mm/1h
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total IgM
Qual: positive
Quant: 26.00 mg/dl
Source: this donation
40.00 - 230.00 mg/dl
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: previous donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295201
1 mL ($43.13)
Available ($225.00)

Human Serum - Anti-Neutrophil Cytoplasmic Antibodie... - E03.9

Donor:
Gender: Female Age: 71
Diagnosed disease:
I10.90
Parameter:
25-Hydroxy-Vitamin D3 (Calcidiol) Anti-Bone-specific Alkaline Phosphatase (BAP) Anti-Neutrophil Cytoplasmic Antibodies (ANCA) Anti-SS-A (Ro) Anti-SS-B (La) Anti-Smith (Sm) Anti-U1 small nuclear ribonucleoprotein (U1-snRNP) Anti-double-stranded DNA (dsDNA) Antinuclear Antibodies (ANA) Capsule-reactive protein (CRP) ...
Open
Donor:
Gender:
Female
Age:
71 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • I10.90
Parameter Result Ref. / Cut-Off Measuring Information
25-Hydroxy-Vitamin D3 (Calcidiol)
Qual: negative
Quant: 40.8 ng/mL
Source: this donation
30.00 - 100 ng/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Anti-Bone-specific Alkaline Phosphatase (BAP)
Qual: negative
Quant: 12.9 µg/L
Source: this donation
5.50 - 27.10 µg/L
Remarks: sex and age dependent
Method: EIA (Enzyme Immuno Assay)
System: ISYS IDS
Anti-Neutrophil Cytoplasmic Antibodies (ANCA)
Qual:
Quant: not specified Titer
Source: this donation
Remarks: subsequent claim possible
negative Titer
Method: IIFT (Indirect Immunfluorescence Test)
System: iPro EUROIMMUN AG
Anti-SS-A (Ro)
Qual: negative
Quant: 0.6 U/mL
Source: this donation
< 25.00 U/mL
Remarks: 15,00 -25,00 borderline
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-SS-B (La)
Qual: negative
Quant: 1.1 U/mL
Source: this donation
< 25.00 U/mL
Remarks: 15,00 -25,00 borderline
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-Smith (Sm)
Qual: negative
Quant: 2.5 U/mL
Source: this donation
< 25.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-U1 small nuclear ribonucleoprotein (U1-snRNP)
Qual: negative
Quant: 1.2 U/mL
Source: this donation
< 25.00 U/mL
Remarks: 15,00 -25,00 borderline
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-double-stranded DNA (dsDNA)
Qual: negative
Quant: 3.9 IU/mL
Source: this donation
< 20.00 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Antinuclear Antibodies (ANA)
Qual:
Quant: not specified Titer
Source: this donation
Remarks: subsequent claim possible
negative Titer
Method: IIFT (Indirect Immunfluorescence Test)
System: iPro ORGENTEC Diagnostika GmbH
Capsule-reactive protein (CRP)
Qual: negative
Quant: 1.38 mg/L
Source: this donation
0.00 - 3.00 mg/L
Method: Nephelometry
System: BN ProSpec Siemens
Complement C3
Qual: negative
Quant: 1.1 g/L
Source: this donation
0.90 - 1.80 g/L
Method: Nephelometry
System: BN ProSpec Siemens
Complement C4
Qual: negative
Quant: 0.29 g/L
Source: this donation
0.10 - 0.40 g/L
Method: Nephelometry
System: BN ProSpec Siemens
Osteocalcin
Qual: negative
Quant: 32.6 ng/mL
Source: this donation
10.40 - 45.60 ng/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Parathyroid hormone (PTH)
Qual: negative
Quant: 66.7 pg/mL
Source: this donation
11.50 - 78.40 pg/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Rheumatoid Factor (RF) IgA
Qual: negative
Quant: 3.5 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Rheumatoid Factor (RF) IgG
Qual: negative
Quant: 4 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 1.00 IU/mL
Source: this donation
< 20.00 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Serum Crosslaps
Qual: negative
Quant: 0.58 ng/mL
Source: this donation
0.14 - 1.35 ng/mL
Remarks: sex and age dependent
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH59701
0.6 mL ($77.63)
Available ($225.00)

Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E66.99

Donor:
Gender: Female Age: 30 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
enalapril
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb)
Open
Donor:
Gender:
Female
Age:
30 Years
Ethnic group:
European/Caucasian
BMI:
39 kg/m²
Blood type:
Not specified
Rhesus factor:
not specified
Weight:
119 kg
Height:
175 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • E66.99
  • I10.90
Medication:
  • enalapril (Dosages: 1/day)
  • metformin (Dosages: 2000/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: positive
Quant: > 600.00 kIU/L
Source: previous donation
< 34.00 kIU/L
Method: not specified
System: Cobas Modular Roche
TSH Receptor Antibodies (TRAb)
Qual: positive
Quant: 1.38 IU/L
Source: previous donation
< 1.22 IU/L
Remarks: borderline: 1,22 - 1,75
Method: not specified
System: Cobas Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344822
1 mL ($43.13)
Available ($225.00)

Human K2EDTA plasma - E06.9

Donor:
Gender: Female Age: 39 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH)
Open
Donor:
Gender:
Female
Age:
39 Years
Ethnic group:
European/Caucasian
BMI:
33 kg/m²
Weight:
94.5 kg
Height:
170 cm
Sample:
Matrix:
K2EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Thyroiditis, unspecified [E06.9]
  • H93.1B
  • I10.90
  • hypothyroidism
Medication:
  • L-thyroxine (Dosages: 125µg/day)
  • candesartan (Dosages: 16mg/day)
  • diltiazem (Dosages: 60mg/day)
  • indapamide (Dosages: 2.5mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: negative
Quant: < 9.00 kIU/L
Source: previous donation
< 34.00 kIU/L
Method: not specified
System: Cobas Modular Roche
TSH Receptor Antibodies (TRAb)
Qual: negative
Quant: 1.06 IU/L
Source: previous donation
< 1.22 IU/L
Remarks: borderline: 1,22 - 1,75
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual: negative
Quant: 1.04 mU/L
Source: this donation
Remarks: sensitive
0.270 - 4.200 mU/L
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 e-Module Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH322028
1 mL ($43.13)
Available ($225.00)

Human K2EDTA plasma - E05.9

Donor:
Gender: Male Age: 54 Ethnic group: European/Caucasian
Diagnosed disease:
I10.9
Medication:
candesartan
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH)
Open
Donor:
Gender:
Male
Age:
54 Years
Ethnic group:
European/Caucasian
BMI:
25 kg/m²
Weight:
80 kg
Height:
180 cm
Sample:
Matrix:
K2EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Thyrotoxicosis, unspecified [E05.9]
  • I10.9
Medication:
  • candesartan (Dosages: 16mg)
  • thiamazole
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: negative
Quant: < 9.00 kIU/L
Source: previous donation
< 34.00 kIU/L
Method: not specified
System: Cobas Modular Roche
TSH Receptor Antibodies (TRAb)
Qual: negative
Quant: < 0.80 IU/L
Source: previous donation
< 1.22 IU/L
Remarks: borderline: 1,22 - 1,75
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual: negative
Quant: 0.39 mU/L
Source: this donation
Remarks: sensitive
0.270 - 4.200 mU/L
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 e-Module Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH322029
1 mL ($43.13)
Available ($225.00)

Human Serum - Anti-Thyroid peroxidase (aTPO / MAK) - E06.3

Donor:
Gender: Female Age: 60 Ethnic group: Not specified
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH)
Open
Donor:
Gender:
Female
Age:
60 Years
Ethnic group:
Not specified
BMI:
23 kg/m²
Weight:
59 kg
Height:
159 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Autoimmune thyroiditis [E06.3]
  • I10.90
Medication:
  • L-thyroxine (Dosages: 50/day)
  • Ramipril (Dosages: 2.5/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: positive
Quant: 216.50 kIU/L
Source: previous donation
< 34.00 kIU/L
Method: not specified
System: Cobas Modular Roche
TSH Receptor Antibodies (TRAb)
Qual: negative
Quant: < 0.30 IU/L
Source: previous donation
< 1.22 IU/L
Remarks: borderline: 1,22 - 1,75
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual: negative
Quant: 1.18 mU/L
Source: this donation
Remarks: sensitive
0.270 - 4.200 mU/L
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 e-Module Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH322030
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Capsule-reactive protein (CRP), Eryth... - I10.90

Donor:
Gender: Male Age: 69 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Metex
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Open
Donor:
Gender:
Male
Age:
69 Years
Ethnic group:
European/Caucasian
BMI:
21 kg/m²
Weight:
62 kg
Height:
170 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Anamneses:
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 0 (information given at the time of donation) (negative RF and ACPA)
  • total points (ACR/EULAR criteria) 5 (information given at the time of donation)
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 0 (information given at the time of donation) (negative RF and ACPA)
  • total points (ACR/EULAR criteria) 5 (information given at the time of donation)
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 0 (information given at the time of donation) (negative RF and ACPA)
  • total points (ACR/EULAR criteria) 5 (information given at the time of donation)
Diseases:
  • I10.90
Medication:
  • Metex (Dosages: 7.5mg/week)
  • Prednisolon (Dosages: 2.5mg/day)
  • folic acid (Dosages: 5mg/week)
  • leflunomide (Dosages: 15mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: positive
Quant: 8.67 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 17.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH303754
1 mL ($43.13)
Available ($225.00)

Human Serum - Anti-Thyroglobulin (aTg / TAK), Anti-... - E06.3

Donor:
Gender: Female Age: 44 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH)
Open
Donor:
Gender:
Female
Age:
44 Years
Ethnic group:
European/Caucasian
BMI:
46 kg/m²
Weight:
130 kg
Height:
169 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Autoimmune thyroiditis [E06.3]
  • Other disorders of intestinal carbohydrate absorption [E74.3]
  • I10.90
Medication:
  • L-thyroxine (Dosages: 50not specified)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroglobulin (aTg / TAK)
Qual: positive
Quant: 64.30 kU/L
Source: this donation
< 40.00 kU/L
Method: CLIA (Chemiluminescence Immuno Assay)
System: Immulite Siemens
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: positive
Quant: 65.90 kU/L
Source: this donation
< 35.00 kU/L
Method: CLIA (Chemiluminescence Immuno Assay)
System: Immulite Siemens
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: positive
Quant: 75.30 kIU/L
Source: previous donation
< 34.00 kIU/L
Method: not specified
System: Cobas Modular Roche
TSH Receptor Antibodies (TRAb)
Qual: negative
Quant: 0.48 IU/L
Source: previous donation
< 1.22 IU/L
Remarks: borderline: 1,22 - 1,75
Method: not specified
System: Cobas Modular Roche
Thyrotropin (TSH)
Qual: negative
Quant: 1.900 mU/L
Source: this donation
Remarks: sensitive
0.270 - 4.200 mU/L
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 e-Module Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH252412
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Capsule-reactive protein (CRP), Eryth... - I10.90

Donor:
Gender: Male Age: 78 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Lodotra
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Open
Donor:
Gender:
Male
Age:
78 Years
Ethnic group:
European/Caucasian
BMI:
29 kg/m²
Weight:
90 kg
Height:
176 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Anamneses:
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 0 (information given at the time of donation) (negative RF and ACPA)
  • total points (ACR/EULAR criteria) 5 (information given at the time of donation)
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 0 (information given at the time of donation) (negative RF and ACPA)
  • total points (ACR/EULAR criteria) 5 (information given at the time of donation)
Diseases:
  • I10.90
Medication:
  • Lodotra (Dosages: 50mg/day)
  • Metex (Dosages: 10mg/week)
  • Quensyl (active agent: hydroxychloroquine)
  • folic acid (Dosages: 5mg/week)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: positive
Quant: 37.09 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 61.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH303750
1 mL ($43.13)
Available ($225.00)

Human Li-heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK) - E06.3

Donor:
Gender: Female Age: 60 Ethnic group: Not specified
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb)
Open
Donor:
Gender:
Female
Age:
60 Years
Ethnic group:
Not specified
BMI:
23 kg/m²
Weight:
59 kg
Height:
159 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Autoimmune thyroiditis [E06.3]
  • I10.90
Medication:
  • L-thyroxine (Dosages: 50/day)
  • Ramipril (Dosages: 2.5/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: positive
Quant: 216.50 kIU/L
Source: previous donation
< 34.00 kIU/L
Method: not specified
System: Cobas Modular Roche
TSH Receptor Antibodies (TRAb)
Qual: negative
Quant: < 0.30 IU/L
Source: previous donation
< 1.22 IU/L
Remarks: borderline: 1,22 - 1,75
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH322106
1 mL ($43.13)
Available ($225.00)
Payment Methods